Category: Oncology/Hematology
Global Oncology/Hematology
-
NAMPT Inhibitors Pipeline Analysis (Phase: Phase II, Phase I/II, Phase I, and Preclinical; and Type of Molecule: Small Molecules and Biologics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Analysis Market – Scope of Report TMR’s report on the global NAMPT inhibitors pipeline analysis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators ... Read More
-
Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Bladder Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Global Diffuse Large B-cell Lymphoma Therapeutics Market - 2022-2029
... by 2028, growing at a CAGR of 7.50 % during the forecast period (2022-2029). Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). DLBCL is an aggressive (fast-growing) NHL that ... Read More
-
Microcatheter Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospital and Ambulatory Surgical Centers) - Global Forecasts to 2027
... reach USD 1,082 million by 2027 from USD 828 million in 2022, at a CAGR of 5.5% during the forecast period. Factors such as the growing adoption of minimally invasive procedures, rising geriatric individuals, Increasing ... Read More
-
Cancer Diagnostics Oncology Companion Diagnostics Market Research Report 2022-2030
... growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Cancer Diagnostics Oncology Companion ... Read More
-
Flow Cytometry in Oncology Market Research Report 2022-2030
... market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Flow Cytometry ... Read More
-
Global Virtual Clinical Trials Market by Study Design (Interventional, Observational, Expanded Access), by Indication (Oncology, Cardiovascular, Others), and by Region - 2022 to 2032
... the global virtual clinical trials market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to ... Read More
-
Cancer/Tumor Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
... projected to reach USD 16.0 Billion by 2027 from USD 9.7 Billion in 2022, at a CAGR of 10.6% during the forecast period. Growth in this market is majorly driven by rising funding investments in ... Read More
-
Global Immunoassays Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type (Reagents & Kits, Analyzers/Instruments, and Software & Services), Application (Cardiology, Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Technology (Radio immunoassay (RIA), Enzyme Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions (North America, Asia Pacific, Europe, Latin America, Middle East and Africa)
... Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions ... Read More
-
Global Biomarkers Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type (Molecular, Radiographic, Histologic, Physiologic), Application (Disease Susceptibility/Risk, Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), Disease (Oncology, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders) and Regions (North America, Asia Pacific, Europe, Latin America Middle East and Africa)
... Disorders) and Regions (North America, Asia Pacific, Europe, Latin America Middle East and Africa) Market Overview: Biomarkers are biological measures used to conduct a diagnostic evaluation, such as blood pressure or cholesterol level, as well ... Read More
-
Global Melanoma Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market Segmentation Global Melanoma Cancer Diagnostics Market, By Product ... Read More
-
Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027By Ecosystem (Precision Diagnostics, Precision Therapeutics, Applied Sciences, Digital Health, and Information Technology), Precision Diagnostics (Molecular Diagnostics v/s Medical Imaging), Precision Therapeutics (Clinical Trials, Cell Therapy, Drug Discovery & Research, Gene Therapy), Applied Sciences (Genomics, Pharmacogenomics, Others), Digital Health, and Information Technology (Clinical Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics, In-Silico Informatics, Others), By Application (Solid Tumor v/s Hematological Malignancies), Solid Tumor (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others), Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Leukemia, Others), and By Region
... (Clinical Trials, Cell Therapy, Drug Discovery & Research, Gene Therapy), Applied Sciences (Genomics, Pharmacogenomics, Others), Digital Health, and Information Technology (Clinical Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics, In-Silico Informatics, Others), By Application ... Read More
-
Global Cervical Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030 Market Segmentation Global Cervical Cancer Diagnostic Market, By Product ... Read More
-
Global Pituitary Cancer Market - 2022-2029
... 9.4% during the forecast period (2022-2029). Pituitary cancer is characterized by abnormal growth in the pituitary gland. It affects the functioning of the pituitary gland and may cause an increased or decreased level of pituitary ... Read More
-
Cancer Diagnostics Market (Test Type: Tumor Biomarker Tests, Imaging, Endoscopy, and Biopsy; End-user: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... – Scope of Report TMR’s report on the global cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during ... Read More
-
Global Nasopharyngeal Cancer Market - 2022-2029
... % during the forecast period (2022-2029). Nasopharyngeal cancer is a rare therapy of malignant cancer that appears in the nasopharynx. It is the upper part of the throat behind the nose. The nasopharynx is situated ... Read More
-
Global Chronic Lymphocytic Leukemia Therapeutics Market - 2022-2029
... a CAGR of 7.90% during the forecast period (2022-2029). Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL predominantly affects the B-cell lymphocytes involved in producing ... Read More
-
Global Castrate Resistant Prostate Cancer Therapeutics Market - 2022-2029
... growing at a CAGR of 8.4% during the forecast period (2022-2029). Castration-resistant prostate cancer is stated as prostate cancer that is scattered to other parts of the body. Several risk factors for castration-resistant prostate cancer ... Read More
-
Global Cancer Molecular Diagnostics Market - 2022-2029
... CAGR of 6.30% during the forecast period (2022-2029). Cancer molecular diagnostics include the detection, diagnosis, sub-classification, prognosis, and monitoring response to therapy. These techniques identify the alterations in DNA or RNA sequences, associated with cancer. ... Read More
-
Global Oncology Therapy Market - 2022-2029
... during the forecast period (2022-2029). Cancer therapies are medications designed to limit cancer growth and proliferation by interfering with specific molecules involved in the growth and expansion of malignant cells, such as proteins or DNA. ... Read More
-
Companion Diagnostics for Oncology Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
... change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Companion Diagnostics for Oncology market size is growing at a ... Read More
-
Global Hematology Market - 2022-2029
... % during the forecast period (2022-2029). Hematology is a branch of medicine that deals with diagnosing, treating, and preventing blood, blood-forming organs, and blood diseases such as blood cancer, anemia, hemophilia, and blood clots. Hematological ... Read More
-
Global Cervical Cancer Treatment Market - 2022-2029
... cervix is the lower part of the uterus that connects to the vagina. Cervical cancer begins in the cells of the cervix. Most cervical malignancies are caused by strains of the sexually transmitted pathogen, Human ... Read More
-
Global Cancer Vaccines Market - 2022-2029
... forecast period (2022-2029). Cancer is a malignant tumor caused by uncontrollable cell development in the body. It can be treated with a variety of drugs and vaccinations. Vaccines are widely classified as either preventative or ... Read More
-
Global Skin Cancer Market - 2022-2029
... to abnormal growth of skin cells. It is estimated that 90% of skin cancer is caused majorly due to solar and artificial ultraviolet radiation (UV). Ultraviolet radiation is a primary carcinogen that results in UV-induced ... Read More
Research Assistance
